對性行為感染感染 (STI) 診斷市場到 2035 年的分析和預測：按類型、產品類型、服務、技術、組件、應用、最終用戶和交付形式。

全球性行為感染（STI）診斷市場預計將從2025年的45億美元成長到2035年的78億美元，年複合成長率（CAGR）為5.5%。性傳染病（STD）診斷市場結構較為一體化，主要細分市場包括臨床檢測（約佔市場佔有率的60%）和即時檢測（約佔市場佔有率的40%）。主要產品類型包括核酸增幅檢查（NAAT）、免疫檢測和快速診斷測試。該市場的成長主要受性行為感染盛行率上升以及對早期準確診斷日益重視的推動。銷售量分析表明，每年都有大量的診斷試劑盒和測試被使用，這反映出市場對性行為感染檢測解決方案的持續需求。

此應用領域主要集中於各種性行為感染（ STI）的診斷，其中披衣菌感染和淋病檢測最為常見，因為這兩種感染的盛行率很高。受全球衛生舉措和篩檢活動加強的推動，愛滋病毒檢測也佔了相當大的佔有率。性行為感染盛行率的上升和國家篩檢計畫的實施正在推動該領域的需求，人們正明顯地轉向綜合檢測解決方案。

終端用戶群包括醫院、診斷檢查室和診所。診斷檢查室憑藉其先進的基礎設施和全面的檢測能力，佔據了相當大的市場佔有率。診所和醫院正擴大採用快速檢測解決方案，以提供即時的醫療護理和諮詢。預計新興市場醫療基礎設施的擴張和先進診斷技術的整合將推動該領域的成長。

區域概覽

北美憑藉其高度發展的醫療保健體系和對預防醫學的重視，在性行為感染（STI）診斷市場佔據領先地位。該地區擁有廣泛的先進診斷技術，包括分子診斷和快速就地檢驗，從而能夠實現早期精準檢測。政府主導的篩檢計畫、公共衛生宣傳宣傳活動和定期檢測顯著推動了市場需求。此外，優惠的報銷政策和持續的監管支持促進了創新和新型診斷解決方案的應用。領先的診斷研發公司及其對研發的持續投入，進一步鞏固了該地區作為該市場主要收入來源的地位。

亞太地區是性行為感染（STI）診斷領域成長最快的市場，這主要得益於醫療基礎設施的不斷改善和性健康意識的日益增強。該地區各國政府正日益重視透過全國性的篩檢計畫和宣傳宣傳活動來推動早期診斷。龐大且多元化的人口，加上醫療服務可近性的不斷提高，使得對價格合理且易於獲取的診斷解決方案的需求強勁。快速檢測和即時檢測技術的日益普及，提高了檢測率，尤其是在醫療資源匱乏的地區。此外，國內外診斷公司加強投資，也加速了該地區新興經濟體的創新和市場滲透。

主要趨勢和促進因素

性行為感染感染發生率上升：

性行為感染感染（STI）如披衣菌感染、淋病、梅毒和愛滋病等疾病發生率的上升是性行為感染診斷市場發展的主要因素。生活方式的改變、無保護性行為以及某些人群缺乏相關意識，都加劇了疾病負擔。這促使各國政府和醫療機構更加重視早期檢測和定期篩檢計畫。預防長期併發症和防止感染擴散的需求進一步推動了檢測需求的成長。因此，醫療系統正在增加對先進快速診斷技術的投資，從而顯著加速了市場成長。

擴大即時檢測和居家檢測範圍：

對便捷易用的檢測解決方案日益成長的需求，為性行為感染(STI) 診斷市場帶來了巨大的機會。即時檢測和居家檢測套組無需大規模檢測機構即可快速獲得檢測結果，從而改善了都市區和偏遠地區的檢測服務。這些解決方案尤其有助於消除與性行為感染檢測相關的污名，鼓勵更多人接受檢測。分子診斷技術的進步以及與數位醫療的融合，正在提升檢測的準確性和便利性。隨著消費者偏好轉向注重隱私和便利性，各公司正加大對創新自測檢測套組的投資，為新興市場和已開發市場都創造了強勁的成長潛力。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制因素
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章：細分市場分析

• 市場規模及預測：依類型
  • 披衣菌感染檢測
  • 淋病檢測
  • 梅毒檢測
  • 單純皰疹病毒檢測
  • 人類乳突病毒 (HPV) 檢測
  • 愛滋病毒檢測
  • 滴蟲檢測
  • B型肝炎檢測
  • 丙型肝炎檢測
  • 其他
• 市場規模及預測：依產品分類
  • 試劑盒和試劑
  • 裝置
  • 軟體
  • 其他
• 市場規模及預測：依服務分類
  • 臨床實驗室服務
  • 即時檢測服務
  • 諮詢服務
  • 其他
• 市場規模及預測：依技術分類
  • 分子診斷
  • 免疫檢測
  • 即時檢測
  • 快速診斷測試
  • 其他
• 市場規模及預測：依組件分類
  • 分析器
  • 消耗品
  • 其他
• 市場規模及預測：依應用領域分類
  • 醫院
  • 診所
  • 診斷檢測實驗室
  • 居家醫療
  • 其他
• 市場規模及預測：依最終用戶分類
  • 醫療保健提供者
  • 診斷中心
  • 普通用戶
  • 公共衛生研究所
  • 其他
• 市場規模及預測：依實施方法分類
  • 臨床試驗
  • 即時檢測
  • 家庭測試
  • 其他

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 供需差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 監管概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 大公司的策略

第8章：公司簡介

• Abbott Laboratories
• Roche Diagnostics
• Hologic
• Becton Dickinson and Company
• bioMerieux
• Siemens Healthineers
• Thermo Fisher Scientific
• Danaher Corporation
• Qiagen
• Cepheid
• Bio-Rad Laboratories
• Quidel Corporation
• OraSure Technologies
• Grifols
• PerkinElmer
• Luminex Corporation
• Meridian Bioscience
• GenMark Diagnostics
• Myriad Genetics
• Alere

第9章 關於我們

The global STD Diagnostics market is projected to grow from $4.5 billion in 2025 to $7.8 billion by 2035, at a compound annual growth rate (CAGR) of 5.5%. The STD diagnostics market is characterized by a moderately consolidated structure, with the top segments being laboratory testing at approximately 60% market share and point-of-care testing at around 40%. Key product categories include nucleic acid amplification tests (NAATs), immunoassays, and rapid diagnostic tests. The market is driven by the increasing prevalence of sexually transmitted diseases and the growing emphasis on early and accurate diagnosis. Volume insights indicate a significant number of diagnostic kits and tests being utilized annually, reflecting the ongoing demand for STD testing solutions.

The Application segment focuses on the diagnosis of various STDs, with chlamydia and gonorrhea testing being the most prevalent due to their high incidence rates. HIV testing also represents a substantial portion, driven by global health initiatives and increased screening efforts. The rising prevalence of STDs and the implementation of national screening programs are propelling demand in this segment, with a notable shift towards integrated testing solutions.

End User segmentation includes hospitals, diagnostic laboratories, and clinics, with diagnostic laboratories holding a significant share due to their advanced infrastructure and comprehensive testing capabilities. Clinics and hospitals are increasingly adopting rapid testing solutions to provide immediate care and counseling. The expansion of healthcare infrastructure and the integration of advanced diagnostic technologies in emerging markets are expected to boost growth in this segment.

Geographical Overview

North America leads the STD diagnostics market due to its highly developed healthcare ecosystem and strong emphasis on preventive care. The region benefits from widespread availability of advanced diagnostic technologies, including molecular and rapid point-of-care tests, which support early and accurate detection. Government-backed screening programs, public health awareness campaigns, and routine testing practices significantly drive demand. In addition, favorable reimbursement frameworks and consistent regulatory support encourage innovation and adoption of new diagnostic solutions. The presence of leading diagnostic developers and continuous investment in research further strengthen the region's position as the primary revenue contributor in this market.

Asia Pacific is the fastest-growing region in the STD diagnostics market, driven by expanding healthcare infrastructure and rising awareness of sexual health. Governments across the region are increasingly focusing on early diagnosis through national screening initiatives and awareness campaigns. Large and diverse populations, combined with improving access to healthcare services, create strong demand for affordable and accessible diagnostic solutions. The growing adoption of rapid and point-of-care testing technologies is enhancing detection rates, particularly in underserved areas. Additionally, increasing investments from both domestic and global diagnostic companies are accelerating innovation and market penetration across emerging economies in the region.

Key Trends and Drivers

Rising Prevalence of Sexually Transmitted Infections:

The increasing incidence of sexually transmitted infections such as Chlamydia, Gonorrhea, Syphilis, and HIV/AIDS is a primary driver for the STD diagnostics market. Changing lifestyles, unprotected sexual practices, and limited awareness in certain populations contribute to the growing disease burden. This has led governments and healthcare organizations to emphasize early detection and routine screening programs. Increased testing demand is further supported by the need to prevent long-term complications and transmission. As a result, healthcare systems are investing in advanced and rapid diagnostic technologies, significantly accelerating market growth.

Expansion of Point-of-Care and Home-Based Testing :

The growing demand for convenient and accessible testing solutions presents a major opportunity in the STD diagnostics market. Point-of-care and home-based testing kits enable quick results without the need for extensive laboratory infrastructure, improving accessibility in both urban and remote settings. These solutions are particularly valuable in reducing stigma associated with STD testing, encouraging more individuals to get tested. Technological advancements in molecular diagnostics and digital health integration are enhancing accuracy and usability. As consumer preference shifts toward privacy and convenience, companies are increasingly investing in innovative self-testing kits, creating strong growth potential across emerging and developed markets.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Mode

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Chlamydia Testing
  • 4.1.2 Gonorrhea Testing
  • 4.1.3 Syphilis Testing
  • 4.1.4 Herpes Simplex Virus Testing
  • 4.1.5 Human Papillomavirus Testing
  • 4.1.6 HIV Testing
  • 4.1.7 Trichomoniasis Testing
  • 4.1.8 Hepatitis B Testing
  • 4.1.9 Hepatitis C Testing
  • 4.1.10 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Kits & Reagents
  • 4.2.2 Instruments
  • 4.2.3 Software
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Laboratory Testing Services
  • 4.3.2 Point-of-Care Testing Services
  • 4.3.3 Consultation Services
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Molecular Diagnostics
  • 4.4.2 Immunoassays
  • 4.4.3 Point-of-Care Testing
  • 4.4.4 Rapid Diagnostic Tests
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Analyzers
  • 4.5.2 Consumables
  • 4.5.3 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Clinics
  • 4.6.3 Diagnostic Laboratories
  • 4.6.4 Home Care Settings
  • 4.6.5 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Healthcare Providers
  • 4.7.2 Diagnostic Centers
  • 4.7.3 Home Users
  • 4.7.4 Public Health Laboratories
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Mode (2020-2035)
  • 4.8.1 Laboratory Testing
  • 4.8.2 Point-of-Care Testing
  • 4.8.3 Home Testing
  • 4.8.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Mode
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Mode
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Mode
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Mode
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Mode
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Mode
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Mode
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Mode
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Mode
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Mode
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Mode
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Mode
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Mode
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Mode
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Mode
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Mode
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Mode
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Mode
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Mode
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Mode
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Mode
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Mode
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Mode
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Mode

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Roche Diagnostics
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Hologic
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Becton Dickinson and Company
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 bioMerieux
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Siemens Healthineers
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Thermo Fisher Scientific
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Danaher Corporation
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Qiagen
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Cepheid
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Bio-Rad Laboratories
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Quidel Corporation
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 OraSure Technologies
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Grifols
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 PerkinElmer
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Luminex Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Meridian Bioscience
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 GenMark Diagnostics
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Myriad Genetics
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Alere
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us